A detailed history of Ameriprise Financial Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 16,971,232 shares of MRK stock, worth $2.13 Billion. This represents 0.63% of its overall portfolio holdings.

Number of Shares
16,971,232
Previous 16,413,300 3.4%
Holding current value
$2.13 Billion
Previous $1.79 Billion 25.15%
% of portfolio
0.63%
Previous 0.54%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $63.2 Million - $73.6 Million
557,932 Added 3.4%
16,971,232 $2.24 Billion
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $18.9 Million - $20.5 Million
-188,332 Reduced 1.13%
16,413,300 $1.79 Billion
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $44.2 Million - $49.1 Million
-429,593 Reduced 2.52%
16,601,632 $1.71 Billion
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $31.9 Million - $34.7 Million
-293,372 Reduced 1.69%
17,031,225 $1.97 Billion
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $166 Million - $185 Million
-1,613,717 Reduced 8.52%
17,324,597 $1.84 Billion
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $19.1 Million - $24.5 Million
-218,769 Reduced 1.14%
18,938,314 $2.1 Billion
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $117 Million - $132 Million
1,387,491 Added 7.81%
19,157,083 $1.65 Billion
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $91.2 Million - $103 Million
1,092,307 Added 6.55%
17,769,592 $1.62 Billion
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $64.4 Million - $72.2 Million
876,457 Added 5.55%
16,677,285 $1.36 Billion
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $209 Million - $262 Million
2,892,046 Added 22.4%
15,800,828 $1.2 Billion
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $35 Million - $38.5 Million
-488,272 Reduced 3.64%
12,908,782 $970 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $205 Million - $226 Million
-2,908,643 Reduced 17.84%
13,397,054 $1.04 Billion
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $75 Million - $88.3 Million
-1,088,460 Reduced 6.26%
16,305,697 $1.26 Billion
Q4 2020

Feb 12, 2021

SELL
$71.77 - $79.65 $101 Million - $112 Million
-1,411,547 Reduced 7.51%
17,394,157 $1.42 Billion
Q3 2020

Nov 16, 2020

SELL
$73.18 - $82.95 $240 Million - $272 Million
-3,281,920 Reduced 14.86%
18,805,704 $1.56 Billion
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $14.4 Million - $16.4 Million
205,021 Added 0.94%
22,087,624 $1.71 Billion
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $237 Million - $329 Million
3,744,715 Added 20.65%
21,882,603 $1.68 Billion
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $32.9 Million - $37.1 Million
423,984 Added 2.39%
18,137,888 $1.65 Billion
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $138 Million - $151 Million
1,818,130 Added 11.44%
17,713,904 $1.49 Billion
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $14.1 Million - $16.5 Million
201,738 Added 1.29%
15,895,774 $1.33 Billion
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $231 Million - $263 Million
3,317,160 Added 26.8%
15,694,036 $1.31 Billion
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $15.2 Million - $17.6 Million
232,849 Added 1.92%
12,376,876 $946 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $14.6 Million - $17.1 Million
252,584 Added 2.12%
12,144,027 $1.01 Billion
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $172 Million - $202 Million
-3,386,522 Reduced 22.17%
11,891,443 $722 Million
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $345 Million - $401 Million
-6,772,715 Reduced 30.71%
15,277,965 $833 Million
Q4 2017

Feb 12, 2018

SELL
$51.62 - $61.64 $75.6 Million - $90.3 Million
-1,465,197 Reduced 6.23%
22,050,680 $1.24 Billion
Q3 2017

Nov 07, 2017

BUY
$58.67 - $63.13 $1.38 Billion - $1.48 Billion
23,515,877
23,515,877 $1.51 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $318B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.